A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: numb (113)

Records management policy

Description
Records Management Policy Date Issued: Review Date: Document Type: 9 May 2018 19 April 2021 Policy Version: 6 Contents Paragraph 1
Url
/Media/UHS-website-2019/Docs/Policies/Records-management-policy.pdf

Rucaparib

Description
A document based on Rucarib, an ovarian cancer condition.
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Rucaparib.pdf

Niraparib

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCERS Regimen NIRAPARIB • Ovarian Cancer – Niraparib Indication • Niraparib is recommended as maintenance treatment in patients with relapsed,
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Niraparib.pdf

Apalutamide v1

Description
Chemotherapy Protocol PROSTATE APALUTAMIDE Regimen  Prostate cancer Indication  Apalutamide is recommended for non-metastatic prostate cancer as d
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Apalutamide-v1.pdf

Follow up after breast cancer - patient information

Description
This booklet explains what self-supported management is after treatment for early breast cancer and how it works.
Url
/Media/UHS-website-2019/Patientinformation/Cancercare/Follow-up-after-breast-cancer-1107-PIL.pdf

Glasses for children - patient information

Description
This factsheet contains information about your child's glasses test appointment.
Url
/Media/UHS-website-2019/Patientinformation/Eyes/Childrens-eyes/Glasses-for-children-1775-PIL.pdf

Carboplatin (AUC5)-Pegylated Liposomal Doxorubicin (Caelyx)x)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5) - DOXORUBICIN PEGYLATED LIPOSOMAL (Caelyx) Please note this protocol is based on information for the use of the C
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC5-Pegylated-Liposomal-DoxorubicinCaelyxVer1.pdf

VAC31518COV2001_UK_Young Person_ Patient Information Sheet ICF_V2.0_15Feb2021_Clean Localised (3)

Description
Southampton NIHR Clinical Research Facility University Hospital Southampton NHS Foundation Trust C Level West Wing, Mailp
Url
/Media/Southampton-Clinical-Research/Downloads/VAC31518COV2001-UK-Young-Person-Patient-Information-Sheet-ICF-V2.0-15Feb2021-Clean-Localised-3.pdf

Bevacizumab(15mgkg) Carboplatin Gemcitabine (day1)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15)-CARBOPLATIN (AUC4)-GEMCITABINE (day 1) This protocol may require funding Regimen • Ovary-Bevacizumab (15)-Carb
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Bevacizumab15mgkg-Carboplatin-Gemcitabine-day1.pdf

Carboplatin (AUC6) Retreat

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN Retreat Regimen (AUC6) • Ovary – Carboplatin (AUC6) Retreat Indication • Second line or subsequent treatment of platinum sens
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC6Retreat.pdf
1 to 10 of 143
Previous 1 2 3 4 5 … Next